CNS Pharmaceuticals Inc (CNSP)
0.1409
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.135
-0.01
(-4.19%)
After-Hours: 20:00
CNS Pharmaceuticals Cash from Financing (Quarterly): 2.327M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.327M |
| March 31, 2024 | 3.459M |
| December 31, 2023 | 2.178M |
| September 30, 2023 | 0.0084M |
| June 30, 2023 | 2.572M |
| March 31, 2023 | -0.1203M |
| December 31, 2022 | 5.333M |
| September 30, 2022 | -0.1171M |
| June 30, 2022 | -0.1162M |
| March 31, 2022 | 10.51M |
| December 31, 2021 | -0.0828M |
| Date | Value |
|---|---|
| September 30, 2021 | 3.436M |
| June 30, 2021 | 0.8083M |
| March 31, 2021 | 0.3474M |
| December 31, 2020 | 14.18M |
| September 30, 2020 | -0.045M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 8.829M |
| September 30, 2019 | 0.0965M |
| June 30, 2019 | 1.382M |
| March 31, 2019 | -0.048M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.1203M
Minimum
Mar 2023
14.18M
Maximum
Dec 2020
2.680M
Average
0.5779M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
| Oragenics Inc | 0.8212M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.650M |
| Free Cash Flow | -10.76M |
| Free Cash Flow Per Share (Quarterly) | -4.382 |
| Free Cash Flow Yield | -40.24K% |